(Q36566660)

15 August 2017

1 reference

title

Plasma lipoprotein abnormalities in hemodialysis patients--clinical implications and therapeutic guidelines (English)

1 reference

15 August 2017

1 reference

Tetsuo Shoji

1

1 reference

15 August 2017

Yoshiki Nishizawa

series ordinal

2

1 reference

15 August 2017

publication date

1 August 2006

1 reference

Therapeutic Apheresis and Dialysis

15 August 2017

published in

1 reference

15 August 2017

volume

10

1 reference

15 August 2017

issue

4

1 reference

15 August 2017

page(s)

305-315

1 reference

Arterial stiffness in predialysis patients with uremia

15 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-9987.2006.00382.X

Intima-media thickness of carotid artery predicts cardiovascular mortality in hemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-9987.2006.00382.X

Impact of carotid atherosclerosis on long-term mortality in chronic hemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-9987.2006.00382.X

Impact of aortic stiffness on survival in end-stage renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-9987.2006.00382.X

Onset of coronary artery disease prior to initiation of haemodialysis in patients with end-stage renal disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-9987.2006.00382.X

The target of ezetimibe is Niemann-Pick C1-Like 1 (NPC1L1)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-9987.2006.00382.X

ATP-binding cassette transporter A1 and cholesterol trafficking

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-9987.2006.00382.X

Hepatic cholesterol transport from plasma into bile: implications for gallstone disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-9987.2006.00382.X

Paraoxonase 1 activity, concentration and genotype in cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-9987.2006.00382.X

Platelet-activating factor acetylhydrolase: is it good or bad for you?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-9987.2006.00382.X

Atherogenic lipoprotein changes in the absence of hyperlipidemia in patients with chronic renal failure treated by hemodialysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-9987.2006.00382.X

Effect of diabetes on uremic dyslipidemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-9987.2006.00382.X

High prevalence of small dense LDL in diabetic nephropathy is not directly associated with kidney damage: a possible role of postprandial lipemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-9987.2006.00382.X

Abnormal HDL apolipoprotein A-I and A-II kinetics in hemodialysis patients: a stable isotope study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-9987.2006.00382.X

LCAT-dependent conversion of prebeta1-HDL into alpha-migrating HDL is severely delayed in hemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-9987.2006.00382.X

Effect of dialysis flux and membrane material on dyslipidaemia and inflammation in haemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-9987.2006.00382.X

Influence of the type of membrane and heparin on serum lipid parameters during a dialysis session: a pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-9987.2006.00382.X

Blood lipids in haemodialysis patients treated with erythropoietin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-9987.2006.00382.X

Sevelamer hydrochloride with or without alphacalcidol or higher dialysate calcium vs calcium carbonate in dialysis patients: an open-label, randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-9987.2006.00382.X

Effect of MCI-196 (colestilan) as a phosphate binder on hyperphosphataemia in aemodialysis patients: a double-blind, placebo-controlled, short-term trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-9987.2006.00382.X

Non–high-density lipoprotein cholesterol (non-HDL-C) as a predictor of cardiovascular mortality in patients with end-stage renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-9987.2006.00382.X

Hypocholesterolemia is a significant predictor of death in a cohort of chronic hemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-9987.2006.00382.X

Association between cholesterol level and mortality in dialysis patients: role of inflammation and malnutrition

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-9987.2006.00382.X

Hypercholesterolemia and coronary heart disease in the elderly: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-9987.2006.00382.X

The body mass index-mortality relationship in white and African American women

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-9987.2006.00382.X

Reverse epidemiology of conventional cardiovascular risk factors in patients with chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-9987.2006.00382.X

Dietary intake and counseling, weight maintenance, and the course of HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-9987.2006.00382.X

Chronic kidney disease as a metabolic syndrome with malnutrition--need for strict control of risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-9987.2006.00382.X

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-9987.2006.00382.X

Effects of atorvastatin on triglyceride-rich lipoproteins, low-density lipoprotein subclass, and C-reactive protein in hemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-9987.2006.00382.X

Changes in oxidative stress and microcirculation by low-density lipoprotein apheresis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-9987.2006.00382.X

Randomized controlled trial on the efficacy and safety of atorvastatin in patients with type 2 diabetes on hemodialysis (4D study): demographic and baseline characteristics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-9987.2006.00382.X

Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-9987.2006.00382.X

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-9987.2006.00382.X

Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial--Lipid Lowering Arm (ASCOT-LLA): a multicentre ra

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-9987.2006.00382.X

First United Kingdom Heart and Renal Protection (UK-HARP-I) study: biochemical efficacy and safety of simvastatin and safety of low-dose aspirin in chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-9987.2006.00382.X

Why do we need a statin trial in hemodialysis patients?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-9987.2006.00382.X

Study of Heart and Renal Protection (SHARP)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-9987.2006.00382.X

Effect of pravastatin on cardiovascular events in people with chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-9987.2006.00382.X

10.1111/J.1744-9987.2006.00382.X

21 January 2018

Identifiers

DOI

1 reference

15 August 2017

1 reference